These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 4864652)

  • 1. The haemolytic effect of various regimens of primaquine with chloroquine in American Negroes with G6PD deficiency and the lack of an effect of various antimalarial suppressive agents on erythrocyte metabolism.
    Brewer GJ; Zarafonetis CJ
    Bull World Health Organ; 1967; 36(2):303-8. PubMed ID: 4864652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modelling primaquine-induced haemolysis in G6PD deficiency.
    Watson J; Taylor WR; Menard D; Kheng S; White NJ
    Elife; 2017 Feb; 6():. PubMed ID: 28155819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. G6PD deficiency: a classic example of pharmacogenetics with on-going clinical implications.
    Luzzatto L; Seneca E
    Br J Haematol; 2014 Feb; 164(4):469-80. PubMed ID: 24372186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. G6PD deficiency alleles in a malaria-endemic region in the Western Brazilian Amazon.
    Dombrowski JG; Souza RM; Curry J; Hinton L; Silva NRM; Grignard L; Gonçalves LA; Gomes AR; Epiphanio S; Drakeley C; Huggett J; Clark TG; Campino S; Marinho CRF
    Malar J; 2017 Jun; 16(1):253. PubMed ID: 28619120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primaquine alternative dosing schedules for preventing malaria relapse in people with Plasmodium vivax.
    Milligan R; Daher A; Villanueva G; Bergman H; Graves PM
    Cochrane Database Syst Rev; 2020 Aug; 8():CD012656. PubMed ID: 32816320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primaquine for reducing Plasmodium falciparum transmission.
    Graves PM; Gelband H; Garner P
    Cochrane Database Syst Rev; 2012 Sep; (9):CD008152. PubMed ID: 22972117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simultaneous drug reactions in the same patient. Chloroquine-Primaquine sensitivity.
    Stevenson DD; McGerity JL
    JAMA; 1970 Apr; 212(4):624-6. PubMed ID: 5467364
    [No Abstract]   [Full Text] [Related]  

  • 8. Humanized mouse model of glucose 6-phosphate dehydrogenase deficiency for in vivo assessment of hemolytic toxicity.
    Rochford R; Ohrt C; Baresel PC; Campo B; Sampath A; Magill AJ; Tekwani BL; Walker LA
    Proc Natl Acad Sci U S A; 2013 Oct; 110(43):17486-91. PubMed ID: 24101478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hemolysis and primaquine treatment. Preliminary report].
    Menéndez Capote R; Díaz Pérez L; Luzardo Suárez C
    Rev Cubana Med Trop; 1997; 49(2):136-8. PubMed ID: 9685977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Haemolysis in G6PD Heterozygous Females Treated with Primaquine for Plasmodium vivax Malaria: A Nested Cohort in a Trial of Radical Curative Regimens.
    Chu CS; Bancone G; Moore KA; Win HH; Thitipanawan N; Po C; Chowwiwat N; Raksapraidee R; Wilairisak P; Phyo AP; Keereecharoen L; Proux S; Charunwatthana P; Nosten F; White NJ
    PLoS Med; 2017 Feb; 14(2):e1002224. PubMed ID: 28170391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemolytic effects of standard single dosages of primaquine and chloroquine on G-6-PD-deficient caucasians.
    Pannacciulli I; Salvidio E; Tizianello A; Parravidino G
    J Lab Clin Med; 1969 Oct; 74(4):653-61. PubMed ID: 5821522
    [No Abstract]   [Full Text] [Related]  

  • 12. The treatment of malaria in glucose-6-phosphate dehydrogenase deficient patients in Sabah.
    Khoo KK
    Ann Trop Med Parasitol; 1981 Dec; 75(6):591-5. PubMed ID: 7325735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tafenoquine for preventing relapse in people with Plasmodium vivax malaria.
    Rodrigo C; Rajapakse S; Fernando D
    Cochrane Database Syst Rev; 2020 Sep; 9(9):CD010458. PubMed ID: 32892362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primaquine for preventing relapse in people with Plasmodium vivax malaria treated with chloroquine.
    Galappaththy GN; Tharyan P; Kirubakaran R
    Cochrane Database Syst Rev; 2013 Oct; 2013(10):CD004389. PubMed ID: 24163057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. G6PD gene mutations in India producing drug-induced haemolytic anaemia.
    Sukumar S; Colah R; Mohanty D
    Br J Haematol; 2002 Mar; 116(3):671-2. PubMed ID: 11849231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucose-6-phosphate dehydrogenase deficiency in two returning Operation Iraqi Freedom soldiers who developed hemolytic anemia while receiving primaquine prophylaxis for malaria.
    Carr ME; Fandre MN; Oduwa FO
    Mil Med; 2005 Apr; 170(4):273-6. PubMed ID: 15916292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of primaquine standard dose (15 mg/day for 14 days) in the treatment of vivax malaria patients in Thailand.
    Buchachart K; Krudsood S; Singhasivanon P; Treeprasertsuk S; Phophak N; Srivilairit S; Chalermrut K; Rattanapong Y; Supeeranuntha L; Wilairatana P; Brittenham G; Looareesuwan S
    Southeast Asian J Trop Med Public Health; 2001 Dec; 32(4):720-6. PubMed ID: 12041544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Haematological profile of malaria patients with G6PD and PKLR variants (erythrocytic enzymopathies): a cross-sectional study in Thailand.
    Mungkalasut P; Kiatamornrak P; Jugnam-Ang W; Krudsood S; Cheepsunthorn P; Cheepsunthorn CL
    Malar J; 2022 Aug; 21(1):250. PubMed ID: 36038921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The mystery of 'saturation gap' and falsely normal G6PD: a case of primaquine-induced haemolysis in Plasmodium vivax malaria infection.
    Tang ASO; Soo XY; Yeo ST; Mansor NA; Chew LP; Chua HH
    J R Coll Physicians Edinb; 2021 Jun; 51(2):146-148. PubMed ID: 34131671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single Low Dose Primaquine (0.25 mg/kg) Does Not Cause Clinically Significant Haemolysis in G6PD Deficient Subjects.
    Bancone G; Chowwiwat N; Somsakchaicharoen R; Poodpanya L; Moo PK; Gornsawun G; Kajeechiwa L; Thwin MM; Rakthinthong S; Nosten S; Thinraow S; Nyo SN; Ling CL; Wiladphaingern J; Kiricharoen NL; Moore KA; White NJ; Nosten F
    PLoS One; 2016; 11(3):e0151898. PubMed ID: 27010542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.